- Home
- ICCC vs HMR Comparison
ICCC vs HMR Comparison
Compare ICCC & HMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICCC | HMR |
|---|---|---|
| Founded | 1982 | 1984 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.5M | 60.6M |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICCC | HMR |
|---|---|---|
| Price | $6.27 | $1.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 25.5K | ★ 47.7K |
| Earning Date | 02-25-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | $27,769,304.00 | ★ $36,086,264.00 |
| Revenue This Year | N/A | $52.26 |
| Revenue Next Year | N/A | $45.18 |
| P/E Ratio | $24.27 | ★ N/A |
| Revenue Growth | ★ 16.49 | 7.41 |
| 52 Week Low | $4.28 | $0.76 |
| 52 Week High | $7.60 | $10.04 |
Technical Indicators
Market Signals| Indicator | ICCC | HMR |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 61.76 |
| Support Level | $6.15 | $0.87 |
| Resistance Level | $6.92 | $0.94 |
| Average True Range (ATR) | 0.33 | 0.06 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 31.82 | 56.65 |
Price Performance
Historical ComparisonAbout ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About HMR Heidmar Maritime Holdings Corp.
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.